VH Moll, LP
Andrew is an investor and entrepreneur with two decades of success shaping and building companies in life sciences. The co-founder of VentureHealth and InCube Ventures, his passion is biomedical innovation that dramatically improves lives. Andrew's current board seats include Channel Medsystems, Rani Therapeutics, and Sonoma Orthopedic Products, among others.
Prior to joining InCube, Andrew was an active investor with The Angels' Forum and a Partner in the Halo Funds, where he completed his Fellowship and led investments in a portfolio of life science firms. These investments include Intrapace (obesity), Penumbra (ischemic stroke), Sonoma Orthopedic Products, SwitchGear Genomics & Spinal Modulation (pain management).
Prior to becoming a professional investor, Andrew helped to build Operon Technologies into the world's most successful DNA synthesis company, then became a member of the senior executive team within QIAGEN. He began his career at Genentech, where he led teams in various operational and research roles.
Education, Personal, and Fellowship
Andrew holds an MBA from Harvard University and a Bachelor's, with High Honors, from the University of California at Berkeley.
Andrew is a member of Kauffman Fellows Class 9 and served his fellowship under mentor Phil Schlein at The Angels' Forum/Halo Funds. He served as a mentor to Mar Perez (Class 19) and Terence Lam (Class 23).